All discussions about the end of the Covid-19 pandemic hinge on having a viable vaccine. We examine what it will take for this coveted vaccine to reach the stage where it can be widely administered, and can offer the necessary protection that will enable people worldwide to begin to return to normal life. We'll learn how research is progressing, how safety and efficacy will be tested, what it will take for the vaccine to be administered en masse, and how long it takes to be effective. And the big question: When can we expect all of this to happen?
Guests
Ingrid Katz, associate faculty director, Harvard Global Health Institute; affiliated with Harvard Medical School and Brigham and Women's Hospital; board-certified in infectious disease
Cat Lutz (call-in), senior director, mouse repository and in vivo pharmacology; senior research scientist; The Jackson Laboratory
Resources
- Early Trials Show Progress Toward Coronavirus Vaccine
- How Long Does COVID-19 Immunity Last?
- U.S. Says Russian Hackers Are Trying To Steal Coronavirus Vaccine Research
- Mistrust of a Coronavirus Vaccine Could Imperil Widespread Immunity
- What if they make a Covid-19 vaccine but Americans refuse to take it?
- Inside Johnson & Johnson's Nonstop Hunt For A Coronavirus Vaccine
- The Jackson Laboratory: Accelerating Vaccine Development
- hACE2 Transgenic Mouse Model For Coronavirus (COVID-19) Research
